275mg Spegra Dolutegravir Emtricitabinen Tenofovir Alafenamide Tablets

275mg Spegra Dolutegravir Emtricitabinen Tenofovir Alafenamide Tablets Specification

Packaging Type
HDPE bottle

Indication
For the treatment of HIV-1 infection in adults and adolescents

Pacakaging (Quantity Per Box)
1 bottle of 30 tablets

Brand Name
Spegra

Dosage Form
Film-coated tablet

Life Span
24 months from manufacture date

Salt Composition
Dolutegravir, Emtricitabine, Tenofovir Alafenamide

Origin of Medicine
India

Drug Type
Antiretroviral Fixed Dose Combination

Ingredients
Dolutegravir 50 mg, Emtricitabine 200 mg, Tenofovir Alafenamide 25 mg

Physical Form
Tablets

Function
Antiretroviral; treatment of HIV-1 infection

Recommended For
HIV-1 Infected Adults and Adolescents (aged 12 years and older, weighing at least 35 kg)

Dosage
As prescribed by the physician, typically one tablet once daily

Dosage Guidelines
Take exactly as directed by your healthcare provider; do not crush or chew

Storage Instructions
Store in a cool, dry place below 30C. Protect from light and moisture.

Warning
For use under medical supervision only

Prescription Status
Prescription only

Colour
White to off-white tablet

Patient Information Leaflet
Included inside packaging

Contraindications
Known hypersensitivity to any component of the formulation

Shape
Capsule shaped

Administration Route
Oral

Regulatory Status
WHO prequalified (if applicable), Schedule H prescription drug (India)

Imprint
'DT 50/EM 200/TAF 25' on one side

Marketed By
Mylan Pharmaceuticals Pvt. Ltd.

275mg Spegra Dolutegravir Emtricitabinen Tenofovir Alafenamide Tablets Trade Information

Minimum Order Quantity
10 Pieces

Supply Ability
1000 Pieces Per Month

Delivery Time
7 Days

About 275mg Spegra Dolutegravir Emtricitabinen Tenofovir Alafenamide Tablets

Brand Name	Spegra
Packaging Size	30 Tablets
Composition	Dolutegravir(50mg) + Emtricitabine(200mg) + Tenofovir Alafenamide(25mg)
Usage/Application	HIV Infections
Manufacturer	Emcure
Strength	50 mg / 200 mg / 25 mg

Spegra Tablet is a combination of antiretrovirals medicines. It is prescribed to treat HIV (human immunodeficiency virus) infection. It boosts up the immunity to fight against HIV to manage or treat AIDS (acquired immunodeficiency syndrome).

Spegra Tablet restricts the growth of HIV in the body and reduces the risk of getting HIV-related complications to improve the lifespan of an individual. The medicine can be taken with or without food. Taking these medicines regularly at the same time increases their effectiveness. A dose of this medicine should not be missed as it can affect your recovery. It is important to complete the full course of the treatment until your doctor advises you to stop it. Sudden discontinuation of the treatment may affect the potency of the medicine.

The most common side effects of this medicine are headaches, nasal congestion, diarrhea, nausea, weakness and tiredness, cough, and rash. These side effects are generally temporary, but if they persist or become serious inform your doctor. This medicine can also make you feel lazy or weak, so it is advised to avoid driving. Drinking plenty of fluid can help you to cope up with the side effects, so stay hydrated.

Before starting with the treatment, you should consult your doctor if you are pregnant or breastfeeding, or have any health condition. Your doctor may suggest regular blood tests to check your blood counts, kidney and liver functions, and other health conditions. If you are HIV positive, you should not breastfeed or share personal belongings like razors or toothbrushes. Consult your doctor to know about safe sex methods in order to prevent transmission of HIV during intercourse.

Effective HIV-1 Management

Spegra 275mg offers a reliable and convenient option for people living with HIV-1. This advanced, fixed-dose combination therapy streamlines treatment by incorporating three powerful antiretrovirals into a single tablet, taken once daily. With WHO prequalification (where applicable) and production according to stringent pharmaceutical standards, Spegra is suitable for adults and adolescents over 12 years old and weighing at least 35 kg.

Key Ingredients and Dosage

Each Spegra tablet contains Dolutegravir 50 mg, Emtricitabine 200 mg, and Tenofovir Alafenamide 25 mg. This combination inhibits HIV replication effectively. Dosage is typically one tablet daily, as prescribed by your healthcare provider. The product is provided in convenient bottles containing 30 tablets, with a shelf life of 24 months when stored properly as directed.

Usage Guidelines and Safety

Spegra must be taken whole, without crushing or chewing. It is crucial to follow your doctor's instructions and never adjust your dose independently. Do not use if you have hypersensitivity to any ingredient in the formulation. Always consult your healthcare professional for proper usage guidance and report any unusual reactions promptly. A patient information leaflet is included in each package for further details.

FAQ's of 275mg Spegra Dolutegravir Emtricitabinen Tenofovir Alafenamide Tablets:

Q: What is Spegra 275mg used for?

A: Spegra 275mg is indicated for the treatment of HIV-1 infection in adults and adolescents aged 12 years and older who weigh at least 35 kg. It helps to control HIV infection and prevent disease progression when taken as prescribed.

Q: How should I take Spegra 275mg tablets?

A: Take Spegra exactly as your healthcare provider prescribes-typically one film-coated tablet orally once daily. Swallow the tablet whole; do not break, crush, or chew it. Always follow your doctor's instructions for optimal results.

Q: When should Spegra be taken during the day?

A: There is no specific time requirement, but it's recommended to take Spegra at the same time each day to maintain steady medication levels in your body. Consult your physician for specific timing suitable to your regimen.

Q: Who should not take Spegra 275mg?

A: Spegra is contraindicated in individuals with known hypersensitivity to any of its ingredients. Always inform your healthcare provider about allergies or previous reactions to medications before starting this tablet.

Q: What should I do if I miss a dose of Spegra?

A: If you miss a dose, take it as soon as you remember. If it's nearly time for the next dose, skip the missed one and continue with your regular schedule. Do not take two tablets at once to make up for a missed dose. Consult your healthcare professional for further advice.

Q: Where should Spegra be stored for maximum effectiveness?

A: Store Spegra tablets in a cool, dry place below 30C, away from moisture and direct sunlight. Keep the bottle tightly closed and out of reach of children.

Q: What are the main benefits of using Spegra for HIV-1 infection?

A: Spegra simplifies HIV-1 treatment by combining three active ingredients in a single daily tablet, enhancing adherence and effectiveness. It is clinically proven to suppress HIV replication, maintain immune health, and reduce the risk of HIV-related complications when used as prescribed.